(Q34537382)

2 August 2017

title

Histotype predicts the curative potential of radiotherapy: the example of ovarian cancers (English)

1 reference

adaptive radiation therapy

2 August 2017

main subject

0 references

1 reference

M Köbel

4

0 references

C. Blake Gilks

3

object named as

C B Gilks

1 reference

2 August 2017

K D Swenerton

1

1 reference

2 August 2017

J L Santos

2

1 reference

2 August 2017

P J Hoskins

5

1 reference

2 August 2017

F Wong

6

1 reference

2 August 2017

N D Le

7

1 reference

2 August 2017

language of work or name

1 reference

6 August 2010

1 reference

2 August 2017

1 reference

2 August 2017

volume

22

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

341-347

1 reference

Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications.

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030466

Ovarian carcinoma pathology and genetics: recent advances

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030466

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030466

Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030466

A systematic overview of radiation therapy effects in ovarian cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030466

Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030466

Prognostic factors in patients with stage I epithelial ovarian cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030466

Prognostic indices in ovarian cancer. Their significance in treatment planning

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030466

Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030466

Postoperative whole abdominal radiotherapy in clear cell adenocarcinoma of the ovary.

7 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ383

Platinum plus cyclophosphamide plus radiotherapy is superior to platinum alone in 'high-risk' epithelial ovarian cancer (residual negative and either stage I or II, grade 3, or stage III, any grade).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ383

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ383

Lymph node metastasis in grossly apparent stages I and II epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ383

'Moderate-risk' ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelvi-abdominal irradiation

21 January 2018

1 reference

12 December 2020

Lymph node metastasis in stage I epithelial ovarian cancer

1 reference

12 December 2020

Summary and discussion of session recommendations

1 reference

12 December 2020

The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study

1 reference

12 December 2020

Lymph node involvement in epithelial ovarian cancer: sites and risk factors in a series of 355 patients

1 reference

12 December 2020

Toxicity of abdominopelvic radiation in advanced ovarian carcinoma patients after cisplatin/cyclophosphamide therapy and second-look laparotomy

1 reference

12 December 2020

Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy

1 reference

12 December 2020

Ovarian carcinoma: a multivariate analysis of prognostic factors

1 reference

12 December 2020

Early ovarian cancer: what is the staging impact of retroperitoneal node sampling?

1 reference

12 December 2020

Killing time: the consequences of delays in radiotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1093/ANNONC/MDQ383

1 reference

2 August 2017

1 reference

2 August 2017

1 reference